Rapid clearance of a recombinant Salmonella vaccine carrier prevents enhanced antigen-specific CD8 T-cell responses after oral boost immunizations

被引:11
作者
Domènech, VES
Panthel, K
Meinel, KM
Rüssmann, H
机构
[1] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany
[2] Univ Wurzburg, Inst Hyg & Mikrobiol, D-97080 Wurzburg, Germany
关键词
Salmonella enterica serovar typhimurium; bacterial vaccine carrier; type III secretion system; heterologous antigen; CD8 T cell; boost immunization; antivector immunity;
D O I
10.1016/j.micinf.2005.02.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The type III secretion system of Salmonella enterica serovar Typhimurium can be used to target heterologous antigens directly into the cytosol of antigen-presenting cells. Our laboratory has previously reported that the single oral immunization of mice with a recombinant Salmonella strain expressing the translocated Yersinia outer protein E fused to the immunodominant antigen p60 from Listeria monocytogenes results in the efficient induction of p60-specific CD8 T cells and confers protection against a lethal wild-type Listeria challenge infection. In the present study, we investigated whether these antigen-specific cytotoxic T lymphocytes induced by the prime immunization contribute to a more rapid clearance of the vaccine carrier after subsequent boost immunizations and whether oral boost immunizations lead to an augmented p60-specific CD8 T-cell response. We found that the ability of recombinant Salmonella strains to colonize the intestine, mesenteric lymph nodes, and spleen was markedly impaired after boost immunizations but that this effect was independent of existing CD8 T cells reactive with p60(217-225). A significant elevation of antigen-specific CD8 T cells could not be detected by enzyme-linked immumospot assay after the second or the third oral immunization, possibly due to the rapid clearance of the bacterial vaccine carrier from lymphatic organs. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:860 / 866
页数:7
相关论文
共 46 条
[1]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[2]   Oral delivery of foreign antigens by attenuated Salmonella: Consequences of prior exposure to the vector strain [J].
Attridge, SR ;
Davies, R ;
LaBrooy, JT .
VACCINE, 1997, 15 (02) :155-162
[3]  
BAO J X, 1991, Infection and Immunity, V59, P3841
[4]  
CARDENAS L, 1992, CLIN MICROBIOL REV, V5, P328
[5]   Requirement for exported proteins in secretion through the invasion-associated type III system of Salmonella typhimurium [J].
Collazo, CM ;
Galan, JE .
INFECTION AND IMMUNITY, 1996, 64 (09) :3524-3531
[6]   THE MOLECULAR-BASIS FOR THE VIRULENCE OF BACTERIAL PATHOGENS - IMPLICATIONS FOR ORAL VACCINE DEVELOPMENT [J].
DOUGAN, G .
MICROBIOLOGY-SGM, 1994, 140 :215-224
[7]   Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen [J].
Dunstan, SJ ;
Simmons, CP ;
Strugnell, RA .
INFECTION AND IMMUNITY, 1998, 66 (02) :732-740
[8]  
Geginat G, 1999, J IMMUNOL, V162, P4781
[9]   Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes [J].
Gilbert, SC ;
Schneider, J ;
Hannan, CM ;
Hu, JT ;
Plebanski, M ;
Sinden, R ;
Hill, AVS .
VACCINE, 2002, 20 (7-8) :1039-1045
[10]   AROMATIC-DEPENDENT SALMONELLA-TYPHIMURIUM ARE NON-VIRULENT AND EFFECTIVE AS LIVE VACCINES [J].
HOISETH, SK ;
STOCKER, BAD .
NATURE, 1981, 291 (5812) :238-239